Organogenesis Holdings Inc Class A (ORGO)
R&D to Revenue
41.82%
Quarterly · Period ending:
ORGO R&D to Revenue
Latest reported41.82%period ending
Latest reported41.82%period ending
ORGO Quarterly R&D/Revenue (0.00% → 41.82%)
Latest values, visible window
High-resolution chart · PNG
ORGO r&d to revenue history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 41.8169% | |
| 40.7247% | |
| 4.5701% | |
| 8.7855% | |
| 10.3146% | |
| 12.2732% | |
| 9.1034% | |
| 8.981% | |
| 11.9685% | |
| 11.648% | |
| 11.8112% | |
| 9.647% | |
| 9.3235% | |
| 10.4067% | |
| 9.8644% | |
| 8.1936% | |
| 8.406% | |
| 8.8419% | |
| 6.4251% | |
| 7.8706% | |
| 5.9418% | |
| 6.0545% | |
| 5.8976% | |
| 3.6796% | |
| 6.7691% | |
| 8.7637% | |
| 4.8764% | |
| 6.106% | |
| 5.9494% | |
| 5.9013% | |
| 4.8601% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |